SLAM
IONS icon

Swiss Life Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Swiss Life Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$815K Buy
10,275
+1,100
+12% +$82.8K ﹤0.01% 760
2026
Q1 		$689K Buy
9,175
+2,272
+33% +$179K ﹤0.01% 760
2025
Q4 		$546K Buy
6,903
+76
+1% +$5.72K ﹤0.01% 765
2025
Q3 		$447K Buy
+6,827
New +$333K ﹤0.01% 754
2019
Q3 		– Sell
-4,211
Closed -$271K – 530
2019
Q2 		$271K Buy
+4,211
New +$298K ﹤0.01% 516

Other funds holding IONS

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Swiss Life Asset Management's IONS Position: Q2 2026 in Review

Swiss Life Asset Management increased its Ionis Pharmaceuticals (IONS) stake by 12% in Q2 2026, buying an estimated $82.8K and bringing the position to 10,275 shares worth $815K. The position accounts for ﹤0.01% of the portfolio, ranked #760.

Swiss Life Asset Management first reported a position in IONS in Q2 2019 and has held it in 5 quarters since. 320 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Swiss Life Asset Management held 10,275 shares of Ionis Pharmaceuticals worth $815K as of Q2 2026.
  • Swiss Life Asset Management bought 1,100 Ionis Pharmaceuticals shares in Q2 2026, an estimated $82.8K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #760 holding.
  • Swiss Life Asset Management first reported a position in Ionis Pharmaceuticals in Q2 2019 and has held it in 5 quarters since.
  • 320 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.